Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models
- 1 April 2009
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 11 (2), 151-157
- https://doi.org/10.1215/15228517-2008-068
Abstract
Convection-enhanced delivery (CED) with various drug carrier systems has recently emerged as a novel chemotherapeutic method to overcome the problems of current chemotherapies against brain tumors. Polymeric micelle systems have exhibited dramatically higher in vivo antitumor activity in systemic administration. This study investigated the effectiveness of CED with polymeric micellar doxorubicin (DOX) in a 9L syngeneic rat model. Distribution, toxicity, and efficacy of free, liposomal, and micellar DOX infused by CED were evaluated. Micellar DOX achieved much wider distribution in brain tumor tissue and surrounding normal brain tissue than free DOX. Tissue toxicity increased at higher doses, but rats treated with micellar DOX showed no abnormal neurological symptoms at any dose tested (0.1-1.0 mg/ml). Micellar DOX infused by CED resulted in prolonged median survival (36 days) compared with free DOX (19.6 days; p = 0.0173) and liposomal DOX (16.6 days; p = 0.0007) at the same dose (0.2 mg/ml). This study indicates the potential of CED with the polymeric micelle drug carrier system for the treatment of brain tumors.Keywords
This publication has 25 references indexed in Scilit:
- Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenograftsNeuro-Oncology, 2007
- A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulationBritish Journal of Cancer, 2007
- MRI observation of the light-induced release of a contrast agent from photo-controllable polymer micellesPhysics in Medicine & Biology, 2007
- Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor–Positive Glioma Using Boronated CetuximabClinical Cancer Research, 2007
- Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRIProceedings of the National Academy of Sciences of the United States of America, 2007
- Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicinesJournal of Drug Targeting, 2007
- Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts1Neuro-Oncology, 2007
- Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micellesJournal of Controlled Release, 2006
- Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and EfficacyCancer Research, 2006
- Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in ratsJournal of Neurosurgery, 2003